Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Hold On to This NYSE-Listed Consumer Staples Stock - CL

Apr 29, 2022 | Team Kalkine
Hold On to This NYSE-Listed Consumer Staples Stock - CL

 

 

Colgate-Palmolive Company

CL Details

Colgate-Palmolive Company (NYSE: CL) is a consumer and household goods manufacturer. The company's operating segments include Oral, Personal and Home Care and Pet Nutrition. According to market share data, CL is the market leader in Oral Care, with global dominance in the toothpaste and manual toothbrush categories. Some of the brands sold by CL are Colgate, Darlie, Elmex, Hello, Meridol, Sorriso, and Tom's of Maine.

Latest News:

  • Quarterly Dividend and Share Repurchase: The corporation declared a quarterly dividend of USD 0.47 (up by USD 0.02) per common share on March 10, 2022, payable on May 13, 2022, to shareholders of record on April 21, 2021. In addition, the CL board of directors approved a new repurchase programme of up to USD 5.0 billion, which will replace the existing USD 5.0 billion programmes authorized in FY 2018.

Q1FY22 Results:

  • Flat Topline: In Q1FY22, CL reported YoY growth of 1.27% in Net sales to USD 4.40 billion from USD 4.34 billion in Q1FY21, attributable to decline in revenue from Oral, Personal and Home Care segment slightly offset by growth in Pet Nutrition.
  • Reduction in Net Income: Net income for Q1FY22 reduced to USD 559 million compared to USD 681 million in Q1FY21.
  • Cash and Debt Position: As of March 31, 2022, the company had cash & cash equivalents of USD 877 million and total debt (including notes payables) of USD 7.61 billion.

Key Risk:

  • Exchange Rate Risk: Since CL sells its products in over 200 countries and territories, the company is subject to currency changes due to manufacturing and selling in currencies other than the US dollar.
  • Commodity Price Risk: Price fluctuation of raw commodities utilized in production, such as essential oils, resins, tropical oils, pulp, tallow, corn, chicken, and soybeans, exposes the company to commodity price risk.

Outlook:

  • FY22 Estimates: As of April 29, 2022, CL anticipates net sales growth of 1% to 4% in FY22, with a low-single-digit negative impact from foreign exchange. Organic revenue growth is now expected to be 4% to 6%, per the company. It also expects a lower gross profit margin, more advertising investment, and double-digit earnings-per-share growth on a GAAP basis.

Valuation Methodology: Price/Earnings Per Share Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks. 

Stock Recommendation:

CL's stock price has decreased 6.80% in the past three months and is currently leaning towards the lower end of its 52-week range of USD 72.20 to USD 85.61. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 85.24.

Considering the slight correction in the stock price, solid profitability margins, current valuation, and associated risks. We recommend a "Hold" rating on the stock at the current price of USD 77.39, down 4.72% as of April 29, 2022, at 12:06 PM PDT.

Three-Year Technical Price Chart (as on April 29, 2022, at 12:06 PM PDT). Source: REFINITIV, Analysis by Kalkine Group

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: All forecasted figures and industry information have been taken from REFINITIV.  

Note 3: The report publishing date is as per the Pacific Time Zone.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…